Lupin is set to acquire five legacy pharmaceutical brands, including Piclin, Menoctyl, Sucramal O, Pyridium, and Distaclor, in the fields of gastroenterology, urology, and anti-infectives from Menarini, along with trademark rights. The deal, valued at approximately Rs 100 crore, was announced through a BSE filing, with no further financial details disclosed.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/FxqitVm
